About
Profile
At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world.
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
GILD
Shares of the bio-pharmaceutical company added about 2% after surpassing Wall Street esitmates for its full-year earnings guidance. Gilead now forecasts earnings per share in the range of $4.25 to $4.45 per share, while analysts polled by LSEG were looking for $3.80.
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Gilead Sciences Non-GAAP EPS of $1.72 misses by $0.04, revenue of $7.12B beats by $20M
- Gilead set to roll out Q4 results post-market Tuesday
- Gilead Sciences stock traded in the red for seventh straight session
- Earnings week ahead: Alibaba, PepsiCo, Disney, Palantir, McDonalds, Ford and more
- Arcus Biosciences: Did Gilead Sciences overpay for its latest investment?
- Gilead gets FDA okay for faster Yescarta production process
- Arcus shares extend gains amid mixed reactions on Gilead stake purchase
- Gilead invests $320M in Arcus, expands stake to 33%
- Big Pharma earnings season in spotlight amid positive sentiment
- PBMs ramp up lobbying efforts amid growing public scrutiny
- Gilead stands behind benefits of its CAR-T therapies
- CAR-T therapies to get boxed warning on blood cancer risk
- Gilead in selloff after late-stage setback for Trodelvy
- Biggest stock movers today: Boeing, NuStar Energy, Archer-Daniels-Midland, and more
- Gilead stock drops as Trodelvy fails Phase 3 lung cancer trial
- Eli Lilly’s Jaypirca to lead BTK inhibitor market for leukemia
- Arcus posts early-stage data for Gilead-partnered cancer therapy
- First RSV shots, groundbreaking gene therapy among 2024 drugs to watch
- Health stocks to watch this earnings season as sector poised for resurgence
- Gilead must face negligence claims over HIV drug development, court says
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2023 | 75.06 | 74.78 |
75.33
|
74.24
|
3.4M | 0.43% | ||||
| Oct 6, 2023 | 74.74 | 74.46 |
75.01
|
73.91
|
4.6M | 0.05% | ||||
| Oct 5, 2023 | 74.7 | 74.67 |
75.03
|
74.14
|
4.5M | -0.05% | ||||
| Oct 4, 2023 | 74.74 | 73.3 |
74.82
|
73.25
|
4.6M | 2.01% | ||||
| Oct 3, 2023 | 73.27 | 73.21 |
73.87
|
72.87
|
5.7M | -1.12% | ||||
| Oct 2, 2023 | 74.1 | 75 |
75.04
|
73.16
|
4.6M | -1.12% | ||||
| Sep 29, 2023 | 74.94 | 75.51 |
75.75
|
74.58
|
4.2M | -0.64% | ||||
| Sep 28, 2023 | 75.42 | 75.79 |
76.05
|
75.21
|
3.5M | -0.17% | ||||
| Sep 27, 2023 | 75.55 | 75.67 |
76.06
|
75.14
|
4.4M | 0.03% | ||||
| Sep 26, 2023 | 75.53 | 75.41 |
76.27
|
75.32
|
5.6M | 0.94% | ||||
| Sep 25, 2023 | 74.83 | 74.75 |
74.93
|
74.53
|
3.9M | -0.24% | ||||
| Sep 22, 2023 | 75.01 | 74.76 |
75.61
|
74.35
|
4.4M | -0.35% | ||||
| Sep 21, 2023 | 75.27 | 75.88 |
76.14
|
75.22
|
4.7M | -0.73% | ||||
| Sep 20, 2023 | 75.82 | 75.98 |
76.39
|
75.73
|
4.8M | 0.07% | ||||
| Sep 19, 2023 | 75.77 | 75.39 |
76.13
|
75.25
|
3.9M | 0.20% | ||||
| Sep 18, 2023 | 75.62 | 75.86 |
76.14
|
75.14
|
3.3M | -0.07% | ||||
| Sep 15, 2023 | 75.67 | 77.21 |
77.41
|
75.42
|
11.1M | -2.18% | ||||
| Sep 14, 2023 | 77.36 | 76.79 |
77.73
|
76.74
|
4.4M | 0.06% | ||||
| Sep 13, 2023 | 77.31 | 77 |
77.53
|
76.92
|
4.4M | 0.66% | ||||
| Sep 12, 2023 | 76.8 | 76.99 |
77.23
|
76.28
|
4.2M | -0.31% | ||||
| Sep 11, 2023 | 77.04 | 76.05 |
77.17
|
76
|
8.0M | 1.37% | ||||
| Sep 8, 2023 | 76 | 76.12 |
76.6
|
75.05
|
6.7M | 2.79% | ||||
| Sep 7, 2023 | 73.94 | 74.62 |
74.76
|
73.71
|
6.5M | -0.4% | ||||
| Sep 6, 2023 | 74.24 | 75.12 |
75.14
|
73.25
|
5.7M | -1.22% | ||||
| Sep 5, 2023 | 75.16 | 76.95 |
77
|
75.13
|
6.0M | -1.94% | ||||
| Sep 1, 2023 | 76.65 | 77.22 |
77.41
|
76.47
|
3.0M | 0.22% | ||||
| Aug 31, 2023 | 76.48 | 77.28 |
77.41
|
76.24
|
9.1M | -1.52% | ||||
| Aug 30, 2023 | 77.66 | 78.22 |
78.5
|
77.53
|
3.3M | -0.7% | ||||
| Aug 29, 2023 | 78.21 | 77.25 |
78.25
|
77.05
|
4.2M | 1.52% | ||||
| Aug 28, 2023 | 77.04 | 77.29 |
77.49
|
76.63
|
2.8M | 0.23% | ||||
| Aug 25, 2023 | 76.86 | 76.61 |
77.19
|
76.07
|
3.8M | 0.69% | ||||
| Aug 24, 2023 | 76.33 | 77.25 |
78.14
|
76.29
|
4.8M | -0.92% | ||||
| Aug 23, 2023 | 77.04 | 78.3 |
78.98
|
76.96
|
7.4M | 0.90% | ||||
| Aug 22, 2023 | 76.35 | 75.69 |
76.75
|
75.36
|
4.5M | 0.54% | ||||
| Aug 21, 2023 | 75.94 | 75.67 |
76.26
|
75.54
|
5.4M | 0.08% | ||||
| Aug 18, 2023 | 75.88 | 76.55 |
76.71
|
75.7
|
6.5M | -0.81% | ||||
| Aug 17, 2023 | 76.5 | 77.99 |
78.11
|
76.5
|
5.7M | -1.92% | ||||
| Aug 16, 2023 | 78 | 79.12 |
80.55
|
77.9
|
7.2M | -2.06% | ||||
| Aug 15, 2023 | 79.64 | 79.63 |
80.21
|
78.96
|
3.8M | -0.26% | ||||
| Aug 14, 2023 | 79.85 | 80.06 |
80.42
|
79.52
|
3.7M | -0.19% | ||||
| Aug 11, 2023 | 80 | 80 |
80.13
|
79.46
|
3.4M | 0% | ||||
| Aug 10, 2023 | 80 | 80.38 |
81.09
|
79.95
|
3.6M | -0.21% | ||||
| Aug 9, 2023 | 80.17 | 80.57 |
81.43
|
80.03
|
4.4M | 0.11% | ||||
| Aug 8, 2023 | 80.08 | 80.69 |
80.92
|
78.78
|
5.5M | -0.73% | ||||
| Aug 7, 2023 | 80.67 | 78.33 |
80.96
|
77.93
|
6.8M | 2.53% | ||||
| Aug 4, 2023 | 78.68 | 77.38 |
80.14
|
77.25
|
9.1M | 4.17% | ||||
| Aug 3, 2023 | 75.53 | 75.72 |
75.82
|
75.17
|
5.5M | -0.2% | ||||
| Aug 2, 2023 | 75.68 | 76 |
76.32
|
75.35
|
5.2M | 0% | ||||
| Aug 1, 2023 | 75.68 | 76.09 |
76.38
|
75.1
|
4.0M | -0.6% | ||||
| Jul 31, 2023 | 76.14 | 76.67 |
76.89
|
75.85
|
6.1M | -0.94% | ||||
| Jul 28, 2023 | 76.86 | 76.42 |
77.32
|
76.34
|
5.0M | 0.46% | ||||
| Jul 27, 2023 | 76.51 | 77.33 |
78.28
|
76.4
|
6.3M | -0.88% | ||||
| Jul 26, 2023 | 77.19 | 76.77 |
77.38
|
76.61
|
4.0M | -0.05% | ||||
| Jul 25, 2023 | 77.23 | 77.02 |
78.15
|
76.86
|
5.3M | -0.55% | ||||
| Jul 24, 2023 | 77.66 | 79.82 |
80.18
|
76.25
|
11.3M | -3.7% | ||||
| Jul 21, 2023 | 80.64 | 80.41 |
81.13
|
80
|
15.0M | 0.88% | ||||
| Jul 20, 2023 | 79.94 | 79.56 |
80.78
|
79.54
|
6.0M | 1.24% | ||||
| Jul 19, 2023 | 78.96 | 78.1 |
79.6
|
78.1
|
5.4M | 0.95% | ||||
| Jul 18, 2023 | 78.22 | 77.54 |
78.86
|
77.4
|
5.2M | 0.96% | ||||
| Jul 17, 2023 | 77.48 | 76.67 |
77.76
|
76.46
|
4.9M | 0% | ||||